    <SEC-DOCUMENT>0000950170-25-060324-index.html : 20250429
    <SEC-HEADER>0000950170-25-060324.hdr.sgml : 20250429
    <ACCEPTANCE-DATETIME>20250429171005
    ACCESSION NUMBER:		0000950170-25-060324
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250429
    DATE AS OF CHANGE:		20250429
    EFFECTIVENESS DATE:		20250429

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Eledon Pharmaceuticals, Inc.
    		CENTRAL INDEX KEY:			0001404281
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36620
    		FILM NUMBER:		25889223

    	BUSINESS ADDRESS:
    		STREET 1:		19800 MACARTHUR BLVD.
    		STREET 2:		SUITE 250
    		CITY:			IRVINE
    		STATE:			CA
    		ZIP:			92612
    		BUSINESS PHONE:		949-238-8090

    	MAIL ADDRESS:
    		STREET 1:		19800 MACARTHUR BLVD.
    		STREET 2:		SUITE 250
    		CITY:			IRVINE
    		STATE:			CA
    		ZIP:			92612

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Novus Therapeutics, Inc.
    		DATE OF NAME CHANGE:	20170511

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
    		DATE OF NAME CHANGE:	20070622
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>eldn-2025-ars_proxy_fili.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: eldn-2025-ars_proxy_fili.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>